Litcius/Paper detail

D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients

Antonin Trimaille, Jecko Thachil, Benjamin Marchandot, Anaïs Curtiaud, Ian Léonard-Lorant, Adrien Carmona, Kensuke Matsushita, Chisato Sato, Laurent Sattler, L. Grunebaum, Yves Hansmann, Samira Fafi‐Kremer, Laurence Jesel, Mickaël Ohana, Olivier Morel

2020Journal of Clinical Medicine26 citationsDOIOpen Access PDF

Abstract

Background and Objective: Host defence mechanisms to counter virus infection include the activation of the broncho-alveolar haemostasis. Fibrin degradation products secondary to extravascular fibrin breakdown could contribute to the marked increase in D-Dimers during COVID-19. We sought to examine the prognostic value on lung injury of D-Dimers in non-critically ill COVID-19 patients without thrombotic events. Methods: This study retrospectively analysed hospitalized COVID-19 patients classified according to a D-Dimers threshold following the COVID-19 associated haemostatic abnormalities (CAHA) classification at baseline and at peak (Stage 1: D-Dimers less than three-fold above normal; Stage 2: D-Dimers three- to six-fold above normal; Stage 3: D-Dimers six-fold above normal). The primary endpoint was the occurrence of critical lung injuries on chest computed tomography. The secondary outcome was the composite of in-hospital death or transfer to the intensive care unit (ICU). Results: Among the 123 patients included, critical lung injuries were evidenced in 8 (11.9%) patients in Stage 1, 6 (20%) in Stage 2 and 15 (57.7%) in Stage 3 (p = 0.001). D-Dimers staging at peak was an independent predictor of critical lung injuries regardless of the inflammatory burden assessed by CRP levels (OR 2.70, 95% CI (1.50–4.86); p < 0.001) and was significantly associated with increased in-hospital death or ICU transfer (14.9 % in Stage 1, 50.0% in Stage 2 and 57.7% in Stage 3 (p < 0.001)). D-Dimers staging at peak was an independent predictor of in-hospital death or ICU transfer (OR 2.50, CI 95% (1.27–4.93); p = 0.008). Conclusions: In the absence of overt thrombotic events, D-Dimers quantification is a relevant marker of critical lung injuries and dismal patient outcome.

Topics & Concepts

MedicineFibrinolysisStage (stratigraphy)Intensive care unitD-dimerInternal medicineGastroenterologyLungClinical endpointFibrinCoagulopathyCoronavirus disease 2019 (COVID-19)ImmunologyDiseaseRandomized controlled trialPaleontologyBiologyInfectious disease (medical specialty)COVID-19 Clinical Research StudiesBlood properties and coagulationHeparin-Induced Thrombocytopenia and Thrombosis